FDA Fully Approves Combination for Advanced Endometrial Cancer FDA Fully Approves Combination for Advanced Endometrial Cancer

Pembrolizumab plus lenvatinib for the treatment of patients with advanced endometrial carcinoma is now fully approved.FDA Approvals
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Hematology-Oncology News Alert Source Type: news